Immix Biopharma Inc.

1.75
0.17 (10.76%)
At close: Feb 28, 2025, 3:59 PM
1.73
-0.98%
After-hours: Feb 28, 2025, 05:18 PM EST

Immix Biopharma Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -7.78 -3.68 -1.93 -24.85 -12.73
PEG Ratio -0.18 0.06 -0.00 0.51 n/a
PS Ratio n/a -0.34 n/a n/a n/a
PB Ratio 7.31 2.30 2.62 -6.03 -3.4
P/FCF Ratio -10.5 -4.09 -29.62 -70.5 -15.53
P/OCF Ratio -10.55 -4.09 -29.63 -70.5 -15.68
OCF/S Ratio n/a 0.08 n/a n/a n/a
Debt / Equity Ratio n/a n/a 0.00 -0.87 -1.12
Quick Ratio 5.32 11.70 90.01 0.10 0.20
Current Ratio 5.32 11.70 90.01 0.10 0.20
Asset Turnover n/a -6 n/a n/a n/a
Interest Coverage n/a -16.54K -7.52 -4.45 -7.66
Return on Equity (ROE) -0.94 -0.63 -1.36 0.24 0.27
Return on Assets (ROA) -0.77 -0.55 -1.34 -2.13 -1.03
Return on Capital (ROIC) -1 -0.6 -0.08 0.10 0.23
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a 100.00% n/a n/a n/a
Net Profit Margin n/a 9.19% n/a n/a n/a
Pretax Profit Margin n/a 9.18% n/a n/a n/a
Operating Profit Margin n/a 9.18% n/a n/a n/a
FCF Margin n/a 8.28% n/a n/a n/a
EBITDA Margin n/a 9.18% n/a n/a n/a